Dergiler / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 4

Development of in situ poloxamer-chitosan hydrogels for vaginal drug delivery of benzydamine hydrochloride: Textural, mucoadhesive and in vitro release properties

Sayfa
762–770
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These BNZ mucoadhesive vaginal hydrogel formulations may be a promising alternative to conventional dosage forms for vaginal topical therapy.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The use of in situ hydrogel systems for vaginal drug delivery is an important strategy in the treatment of vaginitis.
📊
Temel Bulgular & Veri:For this purpose BNZ containing hydrogel formulations using thermosensitive polymer (Poloxamer 407) and mucoadhesive polymer (Chitosan H, Chitosan M and Chitosan L) were developed.
💡
Sonuç & Katkı:These BNZ mucoadhesive vaginal hydrogel formulations may be a promising alternative to conventional dosage forms for vaginal topical therapy.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

The use of in situ hydrogel systems for vaginal drug delivery is an important strategy in the treatment of vaginitis. The aim of this study was to develop in situ vaginal hyrogels for benzydamine hydrochloride (BNZ) which were composed of poloxamer and chitosan. The reason for development of these hydrogels was to obtain a vaginal delivery system with improved mechanical and mucoadhesive properties that could provide prolonged retention time for the treatment of vaginits. The hydrogels were also designed for once a day dosage of the drug and to obtain a controlled release of the BNZ. For this purpose BNZ containing hydrogel formulations using thermosensitive polymer (Poloxamer 407) and mucoadhesive polymer (Chitosan H, Chitosan M and Chitosan L) were developed. The hydrogels are composed of polymers which have promising potential for vaginal delivery systems. These formulations were evaluated by rheology, texture, mucoadhesive profiles and drug diffusion with a Franz diffusion cell. It was observed that the diffusion of BNZ from the in situ poloxamer-chitosan hydrogel was more sustained and controlled than with the poloxamer gel. The hydrogel formulations diffused about 65.3±5.1, 80.6±3.8, 88.1±7.3 and 100.4±4.8% of BNZ at 6h. The formulation containing Poloxamer 407 and Chitosan H has the best controlled release profile and mucoadhesive properties, results which indicate that it could suitable for use once a day on the vaginal route. Moreover, the hydrogels higher mucoadhesion exhibited by this formulation prolongs the drug residence time compared with the poloxamer gel and may increase the BNZ efficacy. These BNZ mucoadhesive vaginal hydrogel formulations may be a promising alternative to conventional dosage forms for vaginal topical therapy.

🔖

Bu Makaleye Atıf Yap

DEMİRÖZ, F. T. (2017). Development of in situ poloxamer-chitosan hydrogels for vaginal drug delivery of benzydamine hydrochloride: Textural, mucoadhesive and in vitro release properties. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 4, 762–770. https://ajindex.com/articles/283634

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Deacon MP, McGurk S, Roberts CJ, Williams PM, Tendler SJB, Davies MC, Davis SS, Harding SE. Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems. Biochem J 2000;348: 557–63.
  2. El Kamel A, Sokar M, Naggar V, Al Gamal S. Chitosan and sodium alginate- based bioadhesive vaginal tablets. AAPS Pharm Sci 2002;4: E44. Jones DS, Woolfson AD, Brown AF, O’Neill MJ. Mucoadhesive, syringe- able drug delivery systems for controlled application of metronidazole to the periodontal pocket: in vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J Control Release 1997;49: 71–9.
  3. Cevher E, Sensoy D, Taha MA, Araman A. Effect of thiolated polymers to textural and mucoadhesive properties of vaginal gel formulations prepared with polycarbophil and chitosan. AAPS PharmSciTech 2008;9: 953–65.
  4. Jones DS, Lawlor MS, Woolfson AD. Examination of the flow rheological and textural properties of polymer gels composed of poly(methylvinylether-co- maleic anhydride) and poly(vinylpyrrolidone): rheological and mathematical interpretation of textural parameters. J Pharm Sci 2002;91: 2090–2101.
  5. Jones DS, Lawlor MS, Woolfson AD. Rheological and muchoadhesive characterisation of polymeric systems composed of poly(methylvinylether-co-maleic acid) and poly (vinylpyrrolidone), designed as platforms for topical drug delivery. J Pharm Sci 2003;92: 995–1007.
  6. Ur-Rehman T, Tavelin S, Gröbner G. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels. Int J Pharm 2011;409:19-29.
  7. Machado RM, Palmeira-de-Oliveira A, Gaspar C, Martinezde-Oliveira J, Palmeira-de-Oliveira R. Studies and methodologies on vaginal drug permeation. Adv Drug Deliv Rev 2015;15:14-26.
  8. Ibrahim el-SA, Ismail S, Fetih G, Shaaban O, Hassanein K, Abdellah NH. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application. Acta Pharm 2012;62: 59– 70. Owen DH, Katz DF, A vaginal fluid simulant. Contraception 1999;59: 91–5.
  9. Patel P, Patel P. Formulation and evaluation of clindamycin HCL in situ gel for vaginal application. Int J Pharm Investig 2015;5: 50–6.
  10. Tuğcu-Demiröz F, Acartürk F, Özkul A. Preparation and characterization of bioadhesive controlled-release gels of cidofovir for vaginal delivery. J Biomater Sci Polym Ed 2015;26:1237-55.
  11. Jones DS, Woolfson AD, Brown AF. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm 1997;1